Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Daichi Nishiyama"'
Autor:
Yayoi Matsumura‐Kimoto, Taku Tsukamoto, Yuji Shimura, Yoshiaki Chinen, Kazuna Tanba, Saeko Kuwahara‐Ota, Yuto Fujibayashi, Daichi Nishiyama, Reiko Isa, Junko Yamaguchi, Yuka Kawaji‐Kanayama, Tsutomu Kobayashi, Shigeo Horiike, Masafumi Taniwaki, Junya Kuroda
Publikováno v:
Cancer Medicine, Vol 9, Iss 14, Pp 5185-5199 (2020)
Abstract RSK2 is a serine/threonine kinase downstream signaling mediator in the RAS/ERK signaling pathway and may be a therapeutic target in mantle cell lymphoma (MCL), an almost incurable disease subtype of non‐Hodgkin lymphoma. In this study, ser
Externí odkaz:
https://doaj.org/article/9e1e7146637b4917811ff4b9c406b974
Autor:
Junko Yamaguchi, Takahiro Fujino, Reiko Isa, Daichi Nishiyama, Saeko Kuwahara-Ota, Yuka Kawaji, Taku Tsukamoto, Yoshiaki Chinen, Yuji Shimura, Tsutomu Kobayashi, Shigeo Horiike, Kei Kohno, Shigeo Nakamura, Junya Kuroda
Publikováno v:
Haematologica, Vol 104, Iss 8 (2019)
Externí odkaz:
https://doaj.org/article/65fc80779c1d4266a977513eb1b533d7
Autor:
Akio Onishi, Yayoi Matsumura-Kimoto, Shinsuke Mizutani, Taku Tsukamoto, Takahiro Fujino, Akihiro Miyashita, Daichi Nishiyama, Kazuho Shimura, Hiroto Kaneko, Eri Kawata, Ryoichi Takahashi, Tsutomu Kobayashi, Hitoji Uchiyama, Nobuhiko Uoshima, Yoko Nukui, Yuji Shimura, Tohru Inaba, Junya Kuroda
Publikováno v:
Infection and Drug Resistance. 16:509-519
Akio Onishi,1 Yayoi Matsumura-Kimoto,1,2 Shinsuke Mizutani,1 Taku Tsukamoto,1 Takahiro Fujino,1 Akihiro Miyashita,1,3 Daichi Nishiyama,4 Kazuho Shimura,5 Hiroto Kaneko,5 Eri Kawata,6 Ryoichi Takahashi,7 Tsutomu Kobayashi,1,8 Hitoji Uchiyama,8 Nobuhik
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aad69c422e5e6bac0e4666498cce6909
https://doi.org/10.2147/idr.s396271
https://doi.org/10.2147/idr.s396271
Autor:
Satoshi Inaba, Naoya Nishioka, Hisatoshi Okumura, Koshi Nakao, Yu Hattori, Shun Futamura, Tomohito Hattori, Kengo Okabe, Daichi Nishiyama
Molnupiravir is among the antiviral agents used to treat COVID-19; however, reported data on the efficacy of this drug are based on results from unvaccinated patients. As such, the efficacy of molnupiravir among vaccinated patients during the B1.1.52
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::09cdb0194e72bc6319e60badcded70b4
https://doi.org/10.21203/rs.3.rs-2451986/v1
https://doi.org/10.21203/rs.3.rs-2451986/v1
Autor:
Haruya Okamoto, Yu Inoue, Akihiro Miyashita, Yuka Kawaji-Kanayama, Shotaro Chinen, Takahiro Fujino, Taku Tsukamoto, Yuji Shimura, Shinsuke Mizutani, Hiroto Kaneko, Saeko Kuwahara, Shin-ichi Fuchida, Daichi Nishiyama, Koichi Hirakawa, Junya Kuroda
Publikováno v:
Blood. 140:12321-12322
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7945fc3b9b8d8b030f46cd9a13c7d0ca
https://doi.org/10.1182/blood-2022-157863
https://doi.org/10.1182/blood-2022-157863
Autor:
Yu Inoue, Koichi Hirakawa, Hiroki Hayata, Daichi Nishiyama, Takahiro Fujino, Taku Tsukamoto, Shinsuke Mizutani, Yuji Shimura, Junya Kuroda
Publikováno v:
Annals of Hematology. 102:481-482
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::862b132f22b4fb30b91fe8edb1fc4962
https://doi.org/10.1007/s00277-022-05038-9
https://doi.org/10.1007/s00277-022-05038-9
Autor:
Yoshiaki Chinen, Junya Kuroda, Yuto Fujibayashi, Tsutomu Kobayashi, Reiko Isa, Daichi Nishiyama, Shigeo Horiike, Yayoi Matsumura-Kimoto, Yuji Shimura, Junko Yamaguchi, Taku Tsukamoto, Saeko Kuwahara-Ota, Yuka Kawaji-Kanayama, Masafumi Taniwaki, Kazuna Tanba
Publikováno v:
Cancer Medicine, Vol 9, Iss 14, Pp 5185-5199 (2020)
Cancer Medicine
Cancer Medicine
RSK2 is a serine/threonine kinase downstream signaling mediator in the RAS/ERK signaling pathway and may be a therapeutic target in mantle cell lymphoma (MCL), an almost incurable disease subtype of non‐Hodgkin lymphoma. In this study, serine‐227
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::578999d582d97bce168e4391b604b01e
https://doaj.org/article/9e1e7146637b4917811ff4b9c406b974
https://doaj.org/article/9e1e7146637b4917811ff4b9c406b974
Autor:
Shigeo Horiike, Yayoi Matsumura-Kimoto, Junya Kuroda, Taku Tsukamoto, Saeko Kuwahara-Ota, Tomoko Takimoto-Shimomura, Junko Yamaguchi, Reiko Isa, Yuji Shimura, Daichi Nishiyama, Christian Steinebach, Michael Gütschow, Masafumi Taniwaki, Tsutomu Kobayashi, Yoshimi Mizuno, Yoshiaki Chinen, Yuto Fujibayashi
Publikováno v:
British Journal of Haematology. 191:784-795
An increase in immunosuppressive myeloid-derived suppressor cells (MDSCs) is associated with disease progression and treatment resistance in multiple myeloma (MM). We investigated the mechanisms underlying MDSC induction, and sought to discover a str
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eaf6cbcf98677ea7ebef3eccc80ccb9a
https://doi.org/10.1111/bjh.16881
https://doi.org/10.1111/bjh.16881
Autor:
Junya Kuroda, Junko Yamaguchi, Daichi Nishiyama, Tsutomu Kobayashi, Shigeo Horiike, Yuji Shimura, Reiko Isa, Tomoko Takimoto-Shimomura, Yoshiaki Chinen, Yuto Fujibayashi, Hiroshi Handa, Taku Tsukamoto, Saeko Kuwahara-Ota, Yayoi Matsumura-Kimoto, Masafumi Taniwaki
Publikováno v:
International journal of hematology. 113(3)
Multiple myeloma (MM) is cytogenetically, genetically and molecularly heterogenous even among subclones in one patient, therefore, it is essential to identify both frequent and patient-specific drivers of molecular abnormality. Following previous mol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03ae884053f182aa1707e71305cae086
https://pubmed.ncbi.nlm.nih.gov/33095415
https://pubmed.ncbi.nlm.nih.gov/33095415
Autor:
Atsushi Suzuki, Daichi Nishiyama, Yuji Shimura, Tsutomu Kobayashi, Reiko Isa, Junya Kuroda, Taku Tsukamoto, Saeko Kuwahara-Ota, Junko Yamaguchi, Shigeo Horiike
Publikováno v:
International Journal of Hematology. 112:427-428
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::958e832b8eed9c7370ad54b9edc8a18a
https://doi.org/10.1007/s12185-020-02942-6
https://doi.org/10.1007/s12185-020-02942-6